Startups
Ceres Nanosciences Inc. ("Ceres") is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on its proprietary Nanotrap® technology.
The Nanotrap® technology, coupled with existing research and clinical diagnostic platforms, improves the sensitivity and accuracy of a wide array of critical diagnostic processes. Early detection of biomarkers, in particular those of low abundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs.
Ceres currently sells the Nanotrap® technology for use in a broad range of research and diagnostic applications.
The Nanotrap® technology, coupled with existing research and clinical diagnostic platforms, improves the sensitivity and accuracy of a wide array of critical diagnostic processes. Early detection of biomarkers, in particular those of low abundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs.
Ceres currently sells the Nanotrap® technology for use in a broad range of research and diagnostic applications.
Overview
Location
United States, Virginia, Manassas
Employees
11-50
Total raised
$11.2M
Founded date
2008
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Feb 6, 2017 | Series A round | $3M |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 19, 2024 | Labroots to Host the 12th Annual Cancer Research & Oncology Virtual Event Series on October 2nd, 2024 | Labroots 2024 Cancer Research & Oncology Virtual Event October 2nd Exploring innovations in cancer & oncology research is an essential scientific discipline that conducts cutting-edge research for global cancer prevention, diagnosis... |
| Sep 3, 2024 | NGS Sample Preparation Market Trends Will Exceed US$ 9.5 Billion Value by 2034, at 7.5% CAGR: Prophecy Market Insights | Covina, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Prophecy Market Insights forecasts that the global NGS sample preparation market will grow from US$ 4.9 Billion in 2024 to US$ 9.5 Billion by 2034, driven by a compound annual growth rate (CAGR) of... |
| Apr 6, 2022 | Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative | MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-... |
| Nov 9, 2021 | Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative | MANASSAS, Va., Nov. 9, 2021 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine wastewater-base... |
| Apr 21, 2021 | Ceres Nanosciences Receives $8.2M NIH Award to Improve Wastewater-Based COVID-19 Surveillance | |
| Mar 31, 2017 | Global Sample Preparation Market Is Expected To Reach A Valuation Of US$8.3 bn Exhibiting A CAGR Of 6.6% From 2016 To 2024 | Global Sample Preparation Market Is Expected To Reach A Valuation Of US$8.3 bn Exhibiting A CAGR Of 6.6% From 2016 To 2024 03-31-2017 09:58 AM CET | Business, Economy, Finances, Banking & Insurance Press release from: Sample Preparation... |
| Feb 6, 2017 | Ceres Nanosciences Raises $3M in Series A Financing | Ceres Nanosciences, Inc., a Manassas, Virginia-based biotechnology company, raised $3m in Series A financing. The funding, part of a larger $9m round, was led by GreyBird Ventures, which is committing up to $5.5MM over the next year. In con... |
| Feb 6, 2017 | GreyBird Ventures Leads $3M Series A for Ceres Nanosciences | Ceres Nanosciences, Inc. today announced the completion of a $3MM Million Series A financing as part of a larger, $9MM Series A round. GreyBird Ventures, an early stage venture fund, with offices in Boston, is leading the round. GreyBird is... |
| Feb 3, 2017 | Term Sheet — Friday, February 3 | IPO CHRISTMAS A few highlights from the debutante ball of world’s most secretive company, Snap Inc: Paid Content What you need to know about growing cyberattacks From ExtraHop Income: Snap is losing a ton of money, but revenue grew signific... |
Show more
Reviews 0
FAQ about Ceres Nanosciences, Inc.
When was Ceres Nanosciences, Inc. founded?
Ceres Nanosciences, Inc. was founded in 2008.
How much funding has Ceres Nanosciences, Inc. raised?
Ceres Nanosciences, Inc. has raised $11.2M in total across 2 funding rounds.
What funding rounds has Ceres Nanosciences, Inc. raised?
Parsers VC lists 2 funding rounds of Ceres Nanosciences, Inc., among them a Series A round of $3M on Feb 6, 2017.
What has the press written about Ceres Nanosciences, Inc.?
Parsers VC has collected 11 articles mentioning Ceres Nanosciences, Inc., among them “Labroots to Host the 12th Annual Cancer Research & Oncology Virtual Event Series on October 2nd, 2024” (Sep 19, 2024) and “NGS Sample Preparation Market Trends Will Exceed US$ 9.5 Billion Value by 2034, at 7.5% CAGR: Prophecy Market Insights” (Sep 3, 2024).
Is Ceres Nanosciences, Inc. still active?
Yes, Ceres Nanosciences, Inc. is active; its latest activity on Parsers VC dates from Sep 20, 2024.